A drug with the SMILES CCCN1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc4c(c3)NC(=O)C(C)S4)CC2)CC1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of 23.930\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCCN1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc4c(c3)NC(=O)C(C)S4)CC2)CC1
CCCN1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc4c(c3)NC(=O)C(C)S4)CC2)CC1
2-methyl-6-[4-(4-propylpiperazine-1-carbonyl)piperidin-1-yl]sulfonyl-4H-1,4-benzothiazin-3-one